News Formal

Swiss drug giant Roche reportedly readies to buy the biotech behind the first FDA-approved gene therapy, which just became the priciest medicine in the US

  • 📰 BusinessInsider
  • ⏱ Reading Time:
  • 1 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 51%

Business Business Headlines News

Business Business Latest News,Business Business Headlines

Swiss company Roche nearing a deal to buy Philadelphia-based biotech Spark Therapeutics, the WSJ reported Saturday. Spark's therapy for a rare form of blindness is the most expensive US medicine.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

Hmm

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 729. in BUSİNESS

Business Business Latest News, Business Business Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Roche Nears Deal to Buy Spark Therapeutics for Close to $5 BillionRoche Holding AG is nearing a deal to buy Philadelphia biotech company Spark Therapeutics Inc., according to people familiar with the matter, as the Swiss drugmaker seeks to expand its presence treating hemophilia. Humor Meanwhile $XON Intrexon including Precigen has a current market cap of less than $1.3 billion 🤷‍♂️
Source: WSJ - 🏆 98. / 63 Read more »